SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3o5d'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1BKF_A_FK5A108_1 (FK506 BINDING PROTEIN)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	8 / 9	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 PHE A 130	None	0.84A	1bkfA-3o5dA: 18.5	1bkfA-3o5dA: 32.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1C9H_A_RAPA108_1 (FKBP12.6)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	8 / 12	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TYR A 113 ILE A 122 PHE A 130	None	0.67A	1c9hA-3o5dA: 18.2	1c9hA-3o5dA: 31.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FAP_A_RAPA108_1 (FK506-BINDING PROTEIN)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	9 / 12	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.70A	1fapA-3o5dA: 18.8	1fapA-3o5dA: 32.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FAP_A_RAPA108_1 (FK506-BINDING PROTEIN)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	6 / 12	TYR A 57 PHE A 77 VAL A 86 TRP A 90 ILE A 122 PHE A 130	None	1.15A	1fapA-3o5dA: 18.8	1fapA-3o5dA: 32.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FKB_A_RAPA108_1 (FK506 BINDING PROTEIN)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	8 / 12	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 PHE A 130	None	0.80A	1fkbA-3o5dA: 18.9	1fkbA-3o5dA: 32.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FKB_A_RAPA108_1 (FK506 BINDING PROTEIN)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	5 / 12	TYR A 57 PHE A 77 VAL A 86 TRP A 90 ILE A 122	None	1.20A	1fkbA-3o5dA: 18.9	1fkbA-3o5dA: 32.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FKF_A_FK5A108_1 (FK506 BINDING PROTEIN)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	9 / 11	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.78A	1fkfA-3o5dA: 18.5	1fkfA-3o5dA: 32.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FKJ_A_FK5A108_1 (FK506 BINDING PROTEIN)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	9 / 11	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.78A	1fkjA-3o5dA: 18.5	1fkjA-3o5dA: 32.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FKL_A_RAPA108_1 (FK506 BINDING PROTEIN)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	8 / 12	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 ILE A 122 PHE A 130	None	0.78A	1fklA-3o5dA: 18.9	1fklA-3o5dA: 33.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FKL_A_RAPA108_1 (FK506 BINDING PROTEIN)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	8 / 12	TYR A 57 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.66A	1fklA-3o5dA: 18.9	1fklA-3o5dA: 33.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1MNV_D_DVAD8_0 (ACTINOMYCIN D)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	3 / 3	THR A 15 THR A 17 PRO A 14	None	0.83A	1mnvD-3o5dA: undetectable	1mnvD-3o5dA: 4.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NH8_A_HISA289_0 (ATP PHOSPHORIBOSYLTRANSF ERASE)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	4 / 5	ASP A 203 LEU A 219 ALA A 205 LEU A 206	None	1.11A	1nh8A-3o5dA: undetectable	1nh8A-3o5dA: 22.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1PBK_A_RAPA225_1 (FKBP25)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	8 / 12	TYR A 57 ASP A 68 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.78A	1pbkA-3o5dA: 18.2	1pbkA-3o5dA: 21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1PBK_A_RAPA225_1 (FKBP25)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	8 / 12	TYR A 57 GLY A 84 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.61A	1pbkA-3o5dA: 18.2	1pbkA-3o5dA: 21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1Q6I_A_FK5A301_1 (FKBP-TYPE PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKPA)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	8 / 9	TYR A 57 ASP A 68 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.82A	1q6iA-3o5dA: 14.5	1q6iA-3o5dA: 25.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1Q6I_B_FK5B401_1 (FKBP-TYPE PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKPA)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	5 / 10	ARG A 73 VAL A 86 ILE A 87 TRP A 90 TYR A 113	None	1.48A	1q6iB-3o5dA: 14.4	1q6iB-3o5dA: 25.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1Q6I_B_FK5B401_1 (FKBP-TYPE PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKPA)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	8 / 10	TYR A 57 ASP A 68 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.70A	1q6iB-3o5dA: 14.4	1q6iB-3o5dA: 25.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1T6Z_B_RBFB596_1 (RIBOFLAVIN KINASE/FMN ADENYLYLTRANSFERASE)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	5 / 11	VAL A 186 TYR A 243 GLU A 169 LEU A 206 ILE A 202	None	1.28A	1t6zB-3o5dA: undetectable	1t6zB-3o5dA: 22.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1TCO_C_FK5C509_2 (FK506-BINDING PROTEIN)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	9 / 11	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.83A	1tcoC-3o5dA: 18.5	1tcoC-3o5dA: 32.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XZX_X_T3X500_2 (THYROID HORMONE RECEPTOR BETA-1)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	3 / 3	PHE A 225 ARG A 222 ASN A 238	None	0.93A	1xzxX-3o5dA: undetectable	1xzxX-3o5dA: 21.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1YAT_A_FK5A108_1 (FK506 BINDING PROTEIN)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	9 / 11	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.80A	1yatA-3o5dA: 20.4	1yatA-3o5dA: 23.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2DG3_A_RAPA501_1 (FK506-BINDING PROTEIN 1A)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	8 / 11	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 PHE A 130	None	0.76A	2dg3A-3o5dA: 18.8	2dg3A-3o5dA: 32.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2DG3_A_RAPA501_1 (FK506-BINDING PROTEIN 1A)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	5 / 11	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 122	None	1.19A	2dg3A-3o5dA: 18.8	2dg3A-3o5dA: 32.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2DG4_A_RAPA501_1 (FK506-BINDING PROTEIN 1A)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	7 / 11	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TYR A 113 PHE A 130	None	0.74A	2dg4A-3o5dA: 18.2	2dg4A-3o5dA: 32.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2DG9_A_RAPA501_1 (FK506-BINDING PROTEIN 1A)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	6 / 11	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 PHE A 130	None	0.62A	2dg9A-3o5dA: 18.5	2dg9A-3o5dA: 32.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2DG9_A_RAPA501_1 (FK506-BINDING PROTEIN 1A)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	5 / 11	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 122	None	1.12A	2dg9A-3o5dA: 18.5	2dg9A-3o5dA: 32.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2DG9_A_RAPA501_1 (FK506-BINDING PROTEIN 1A)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	6 / 11	TYR A 57 PHE A 77 VAL A 86 ILE A 87 TYR A 113 PHE A 130	None	0.48A	2dg9A-3o5dA: 18.5	2dg9A-3o5dA: 32.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2FKE_A_FK5A108_1 (FK506 BINDING PROTEIN)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	9 / 11	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.77A	2fkeA-3o5dA: 18.6	2fkeA-3o5dA: 32.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VCD_A_RAPA138_1 (OUTER MEMBRANE PROTEIN MIP)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	7 / 11	TYR A 57 PHE A 67 ASP A 68 VAL A 86 ILE A 87 TRP A 90 TYR A 113	None	1.01A	2vcdA-3o5dA: 14.2	2vcdA-3o5dA: 21.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VN1_A_FK5A501_1 (70 KDA PEPTIDYLPROLYL ISOMERASE)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	8 / 11	TYR A 57 PHE A 67 ASP A 68 PHE A 77 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.88A	2vn1A-3o5dA: 20.6	2vn1A-3o5dA: 39.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VN1_A_FK5A501_1 (70 KDA PEPTIDYLPROLYL ISOMERASE)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	8 / 11	TYR A 57 PHE A 67 PHE A 77 VAL A 86 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.75A	2vn1A-3o5dA: 20.6	2vn1A-3o5dA: 39.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VN1_B_FK5B501_1 (70 KDA PEPTIDYLPROLYL ISOMERASE)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	7 / 10	TYR A 57 ASP A 68 PHE A 77 ILE A 87 TRP A 90 TYR A 113 PHE A 130	None	0.89A	2vn1B-3o5dA: 20.6	2vn1B-3o5dA: 39.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VN1_B_FK5B501_1 (70 KDA PEPTIDYLPROLYL ISOMERASE)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	7 / 10	TYR A 57 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 PHE A 130	None	0.67A	2vn1B-3o5dA: 20.6	2vn1B-3o5dA: 39.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IHZ_A_FK5A501_1 (70 KDA PEPTIDYLPROLYL ISOMERASE, PUTATIVE)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	9 / 10	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.77A	3ihzA-3o5dA: 20.3	3ihzA-3o5dA: 29.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IHZ_A_FK5A501_2 (70 KDA PEPTIDYLPROLYL ISOMERASE, PUTATIVE)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	6 / 8	TYR A 57 ASP A 68 PHE A 77 TRP A 90 TYR A 113 ILE A 122	None	0.59A	3ihzB-3o5dA: 20.9	3ihzB-3o5dA: 29.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KZ7_A_RAPA225_1 (FK506-BINDING PROTEIN 3)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	8 / 10	TYR A 57 ASP A 68 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.78A	3kz7A-3o5dA: 18.4	3kz7A-3o5dA: 20.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3O5R_A_FK5A1001_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	9 / 11	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.72A	3o5rA-3o5dA: 25.2	3o5rA-3o5dA: 88.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3O5R_A_FK5A1001_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	9 / 11	TYR A 57 ASP A 68 VAL A 86 ILE A 87 TRP A 90 TYR A 113 LYS A 121 ILE A 122 PHE A 130	None	0.78A	3o5rA-3o5dA: 25.2	3o5rA-3o5dA: 88.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3UF8_A_FK5A114_1 (UBIQUITIN-LIKE PROTEIN SMT3, PEPTIDYL-PROLYL CIS-TRANS ISOMERASE)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	9 / 10	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.79A	3uf8A-3o5dA: 15.7	3uf8A-3o5dA: 24.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3UQA_A_FK5A114_1 (UBIQUITIN-LIKE PROTEIN SMT3, PEPTIDYL-PROLYL CIS-TRANS ISOMERASE)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	9 / 10	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.84A	3uqaA-3o5dA: 15.8	3uqaA-3o5dA: 24.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3UQB_A_FK5A114_1 (UBIQUITIN-LIKE PROTEIN SMT3, PEPTIDYL-PROLYL CIS-TRANS ISOMERASE)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	8 / 8	TYR A 57 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.65A	3uqbA-3o5dA: 15.7	3uqbA-3o5dA: 25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VAW_A_FK5A114_1 (UBIQUITIN-LIKE PROTEIN SMT3,PEPTIDYL-PROLYL CIS-TRANS ISOMERASE)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	9 / 11	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.82A	3vawA-3o5dA: 15.4	3vawA-3o5dA: 24.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WQW_A_GCSA502_1 (CHITINASE)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	4 / 5	GLY A 93 TRP A 90 ALA A 89 PHE A 129	None	0.98A	3wqwA-3o5dA: undetectable	3wqwA-3o5dA: 20.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4BBO_C_ACTC1113_0 (BLR5658 PROTEIN)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	4 / 4	ASN A 163 ALA A 253 GLY A 165 THR A 167	None	1.35A	4bboC-3o5dA: undetectable	4bboC-3o5dA: 18.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DRH_A_RAPA201_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	6 / 12	ASP A 68 TRP A 90 TYR A 113 LYS A 121 ILE A 122 PHE A 130	None	1.07A	4drhA-3o5dA: 23.4	4drhA-3o5dA: 99.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DRH_A_RAPA201_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	10 / 12	TYR A 57 ASP A 68 PHE A 77 GLN A 85 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.78A	4drhA-3o5dA: 23.4	4drhA-3o5dA: 99.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DRH_D_RAPD201_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	10 / 12	TYR A 57 ASP A 68 PHE A 77 GLN A 85 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.81A	4drhD-3o5dA: 23.6	4drhD-3o5dA: 99.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DRI_A_RAPA201_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	10 / 11	TYR A 57 ASP A 68 PHE A 77 GLN A 85 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.68A	4driA-3o5dA: 23.2	4driA-3o5dA: 99.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DRJ_A_RAPA201_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP4)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	9 / 11	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.72A	4drjA-3o5dA: 22.3	4drjA-3o5dA: 61.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DZ2_A_FK5A200_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	9 / 11	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.80A	4dz2A-3o5dA: 18.9 4dz2B-3o5dA: 19.0	4dz2A-3o5dA: 34.88 4dz2B-3o5dA: 34.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DZ2_B_FK5B200_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	9 / 11	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.78A	4dz2A-3o5dA: 18.9 4dz2B-3o5dA: 19.0	4dz2A-3o5dA: 34.88 4dz2B-3o5dA: 34.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DZ3_A_FK5A201_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	9 / 10	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.80A	4dz3A-3o5dA: 19.0	4dz3A-3o5dA: 34.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DZ3_B_FK5B201_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	8 / 10	TYR A 57 ASP A 68 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.80A	4dz3B-3o5dA: 19.1	4dz3B-3o5dA: 34.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DZ3_B_FK5B201_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	8 / 10	TYR A 57 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.69A	4dz3B-3o5dA: 19.1	4dz3B-3o5dA: 34.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4LAX_A_FK5A301_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP4)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	10 / 10	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 LYS A 121 ILE A 122 PHE A 130	None	0.84A	4laxA-3o5dA: 31.1	4laxA-3o5dA: 57.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4NNR_A_FK5A201_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP2)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	5 / 12	PHE A 77 TRP A 90 TYR A 113 LYS A 121 ILE A 122	None	0.92A	4nnrA-3o5dA: 15.3 4nnrB-3o5dA: 15.3	4nnrA-3o5dA: 27.94 4nnrB-3o5dA: 27.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4NNR_A_FK5A201_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP2)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	9 / 12	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.81A	4nnrA-3o5dA: 15.3 4nnrB-3o5dA: 15.3	4nnrA-3o5dA: 27.94 4nnrB-3o5dA: 27.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4NNR_B_FK5B201_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP2)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	8 / 10	TYR A 57 ASP A 68 VAL A 86 ILE A 87 TYR A 113 LYS A 121 ILE A 122 PHE A 130	None	1.06A	4nnrB-3o5dA: 15.3	4nnrB-3o5dA: 27.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4NNR_B_FK5B201_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP2)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	9 / 10	TYR A 57 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 LYS A 121 ILE A 122 PHE A 130	None	0.85A	4nnrB-3o5dA: 15.3	4nnrB-3o5dA: 27.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ODO_A_FK5A205_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE SLYD)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	5 / 10	TYR A 57 ASP A 68 ILE A 87 TYR A 113 PHE A 130	None	0.78A	4odoA-3o5dA: 10.4	4odoA-3o5dA: 20.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ODO_B_FK5B203_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE SLYD)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	5 / 10	TYR A 57 ASP A 68 ILE A 87 TYR A 113 PHE A 130	None	0.75A	4odoB-3o5dA: 10.0	4odoB-3o5dA: 20.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ODO_C_FK5C204_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE SLYD)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	5 / 10	TYR A 57 ASP A 68 ILE A 87 TYR A 113 PHE A 130	None	0.76A	4odoC-3o5dA: 10.1	4odoC-3o5dA: 20.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ODR_A_FK5A201_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE SLYD, PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP1A CHIMERA)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	6 / 12	TYR A 57 ASP A 68 ILE A 87 TYR A 113 ILE A 122 PHE A 130	None	0.71A	4odrA-3o5dA: 11.3 4odrB-3o5dA: 11.4	4odrA-3o5dA: 16.41 4odrB-3o5dA: 16.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ODR_B_FK5B201_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE SLYD, PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP1A CHIMERA)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	5 / 11	TYR A 57 ASP A 68 ILE A 87 TYR A 113 PHE A 130	None	0.77A	4odrA-3o5dA: 11.3 4odrB-3o5dA: 11.4	4odrA-3o5dA: 16.41 4odrB-3o5dA: 16.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4QT2_A_RAPA202_1 (FK506-BINDING PROTEIN (FKBP)-TYPE PEPTIDYL-PROPYL ISOMERASE)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	9 / 10	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.78A	4qt2A-3o5dA: 20.6	4qt2A-3o5dA: 34.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QT3_A_RAPA202_1 (FK506-BINDING PROTEIN (FKBP)-TYPE PEPTIDYL-PROPYL ISOMERASE)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	9 / 10	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.77A	4qt3A-3o5dA: 19.4	4qt3A-3o5dA: 26.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5B8I_C_FK5C201_3 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	9 / 12	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.84A	5b8iC-3o5dA: 17.9	5b8iC-3o5dA: 32.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5D75_A_FK5A301_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP3)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	8 / 11	TYR A 57 ASP A 68 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.79A	5d75A-3o5dA: 18.3	5d75A-3o5dA: 21.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5GPG_A_RAPA301_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP3)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	8 / 11	TYR A 57 ASP A 68 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.79A	5gpgA-3o5dA: 19.1	5gpgA-3o5dA: 21.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HIE_C_P06C801_2 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	4 / 7	ILE A 122 VAL A 55 CYH A 107 PHE A 79	None	0.98A	5hieC-3o5dA: undetectable	5hieC-3o5dA: 22.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HKG_A_RAPA201_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP1B)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	8 / 12	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TYR A 113 ILE A 122 PHE A 130	None	0.70A	5hkgA-3o5dA: 18.4	5hkgA-3o5dA: 31.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HUA_A_FK5A201_1 (FK506-BINDING PROTEIN 1)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	8 / 11	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 PHE A 130	None	0.81A	5huaA-3o5dA: 20.6	5huaA-3o5dA: 24.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HW8_A_FK5A201_1 (FK506-BINDING PROTEIN 1)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	8 / 11	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122	None	0.81A	5hw8A-3o5dA: 17.1 5hw8D-3o5dA: 17.2	5hw8A-3o5dA: 27.20 5hw8D-3o5dA: 27.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HW8_B_FK5B201_1 (FK506-BINDING PROTEIN 1)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	8 / 11	TYR A 57 ASP A 68 PHE A 77 VAL A 86 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.78A	5hw8B-3o5dA: 17.1	5hw8B-3o5dA: 27.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HW8_C_FK5C201_1 (FK506-BINDING PROTEIN 1)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	8 / 10	TYR A 57 ASP A 68 VAL A 86 ILE A 87 TRP A 90 TYR A 113 LEU A 128 PHE A 130	None	0.74A	5hw8C-3o5dA: 17.0 5hw8H-3o5dA: 14.2	5hw8C-3o5dA: 27.20 5hw8H-3o5dA: 27.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HW8_D_FK5D201_1 (FK506-BINDING PROTEIN 1)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	8 / 11	TYR A 57 ASP A 68 PHE A 77 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.73A	5hw8D-3o5dA: 17.2	5hw8D-3o5dA: 27.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HW8_D_FK5D201_1 (FK506-BINDING PROTEIN 1)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	8 / 11	TYR A 57 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.68A	5hw8D-3o5dA: 17.2	5hw8D-3o5dA: 27.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HW8_E_FK5E201_1 (FK506-BINDING PROTEIN 1)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	6 / 11	TYR A 57 ASP A 68 PHE A 77 ILE A 87 TYR A 113 PHE A 130	None	0.82A	5hw8E-3o5dA: 17.3	5hw8E-3o5dA: 27.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HW8_E_FK5E201_1 (FK506-BINDING PROTEIN 1)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	7 / 11	TYR A 57 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 PHE A 130	None	0.71A	5hw8E-3o5dA: 17.3	5hw8E-3o5dA: 27.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HW8_F_FK5F201_1 (FK506-BINDING PROTEIN 1)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	6 / 12	TYR A 57 ASP A 68 PHE A 77 ILE A 87 TYR A 113 PHE A 130	None	0.75A	5hw8B-3o5dA: 17.1 5hw8F-3o5dA: 14.2 5hw8G-3o5dA: 16.6	5hw8B-3o5dA: 27.20 5hw8F-3o5dA: 27.20 5hw8G-3o5dA: 27.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HW8_F_FK5F201_1 (FK506-BINDING PROTEIN 1)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	7 / 12	TYR A 57 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 PHE A 130	None	0.61A	5hw8B-3o5dA: 17.1 5hw8F-3o5dA: 14.2 5hw8G-3o5dA: 16.6	5hw8B-3o5dA: 27.20 5hw8F-3o5dA: 27.20 5hw8G-3o5dA: 27.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HW8_G_FK5G201_2 (FK506-BINDING PROTEIN 1)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	8 / 11	TYR A 57 ASP A 68 PHE A 77 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.73A	5hw8G-3o5dA: 16.6	5hw8G-3o5dA: 27.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HW8_G_FK5G201_2 (FK506-BINDING PROTEIN 1)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	7 / 11	TYR A 57 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122	None	1.42A	5hw8G-3o5dA: 16.6	5hw8G-3o5dA: 27.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HW8_G_FK5G201_2 (FK506-BINDING PROTEIN 1)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	8 / 11	TYR A 57 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.67A	5hw8G-3o5dA: 16.6	5hw8G-3o5dA: 27.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HW8_H_FK5H201_1 (FK506-BINDING PROTEIN 1)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	6 / 8	TYR A 57 ASP A 68 PHE A 77 ILE A 87 TRP A 90 PHE A 130	None	0.90A	5hw8H-3o5dA: 14.2	5hw8H-3o5dA: 27.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HW8_H_FK5H201_1 (FK506-BINDING PROTEIN 1)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	6 / 8	TYR A 57 PHE A 77 VAL A 86 ILE A 87 TRP A 90 PHE A 130	None	0.83A	5hw8H-3o5dA: 14.2	5hw8H-3o5dA: 27.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HWC_A_FK5A201_1 (FK506-BINDING PROTEIN 1A)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	9 / 11	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.77A	5hwcA-3o5dA: 18.6	5hwcA-3o5dA: 36.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VLM_B_CVIB301_0 (REGULATORY PROTEIN TETR)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	5 / 12	MET A 97 LEU A 134 ILE A 132 VAL A 86 PHE A 77	None	1.31A	5vlmB-3o5dA: undetectable	5vlmB-3o5dA: 22.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VLM_E_CVIE301_0 (REGULATORY PROTEIN TETR)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	5 / 12	MET A 97 LEU A 134 ILE A 132 VAL A 86 PHE A 77	None	1.30A	5vlmE-3o5dA: undetectable	5vlmE-3o5dA: 22.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6G9B_A_IXXA609_1 (ENVELOPE GLYCOPROTEIN,ENVELOP E GLYCOPROTEIN ENVELOPE GLYCOPROTEIN)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	4 / 7	LEU A 142 VAL A 245 LEU A 217 LEU A 219	None	0.69A	6g9bA-3o5dA: undetectable 6g9bB-3o5dA: undetectable	6g9bA-3o5dA: 15.21 6g9bB-3o5dA: 14.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6MKE_A_FK5A201_0 (PEPTIDYLPROLYL ISOMERASE)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	6 / 12	ARG A 73 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113	None	1.48A	6mkeA-3o5dA: 21.0 6mkeD-3o5dA: 20.8	6mkeA-3o5dA: 44.44 6mkeD-3o5dA: 44.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6MKE_A_FK5A201_0 (PEPTIDYLPROLYL ISOMERASE)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	9 / 12	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.77A	6mkeA-3o5dA: 21.0 6mkeD-3o5dA: 20.8	6mkeA-3o5dA: 44.44 6mkeD-3o5dA: 44.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6MKE_B_FK5B201_0 (PEPTIDYLPROLYL ISOMERASE)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	9 / 12	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.75A	6mkeB-3o5dA: 20.9 6mkeC-3o5dA: 20.7	6mkeB-3o5dA: 44.44 6mkeC-3o5dA: 44.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6MKE_C_FK5C201_1 (PEPTIDYLPROLYL ISOMERASE)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	9 / 10	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.76A	6mkeC-3o5dA: 20.7	6mkeC-3o5dA: 44.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6MKE_D_FK5D201_1 (PEPTIDYLPROLYL ISOMERASE)	3o5d	PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5 (Homo sapiens)	9 / 10	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.78A	6mkeD-3o5dA: 20.8	6mkeD-3o5dA: 44.44

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1BKF_A_FK5A108_1","FK506 BINDING PROTEIN","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",8,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;PHE A 130","None","0.84A","1bkfA-3o5dA:18.5","1bkfA-3o5dA:32.20"],["1C9H_A_RAPA108_1","FKBP12.6","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",8,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TYR A 113;ILE A 122;PHE A 130","None","0.67A","1c9hA-3o5dA:18.2","1c9hA-3o5dA:31.64"],["1FAP_A_RAPA108_1","FK506-BINDING PROTEIN","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.70A","1fapA-3o5dA:18.8","1fapA-3o5dA:32.77"],["1FAP_A_RAPA108_1","FK506-BINDING PROTEIN","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",6,"TYR A  57;PHE A  77;VAL A  86;TRP A  90;ILE A 122;PHE A 130","None","1.15A","1fapA-3o5dA:18.8","1fapA-3o5dA:32.77"],["1FKB_A_RAPA108_1","FK506 BINDING PROTEIN","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",8,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;PHE A 130","None","0.80A","1fkbA-3o5dA:18.9","1fkbA-3o5dA:32.77"],["1FKB_A_RAPA108_1","FK506 BINDING PROTEIN","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",5,"TYR A  57;PHE A  77;VAL A  86;TRP A  90;ILE A 122","None","1.20A","1fkbA-3o5dA:18.9","1fkbA-3o5dA:32.77"],["1FKF_A_FK5A108_1","FK506 BINDING PROTEIN","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.78A","1fkfA-3o5dA:18.5","1fkfA-3o5dA:32.77"],["1FKJ_A_FK5A108_1","FK506 BINDING PROTEIN","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.78A","1fkjA-3o5dA:18.5","1fkjA-3o5dA:32.77"],["1FKL_A_RAPA108_1","FK506 BINDING PROTEIN","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",8,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;ILE A 122;PHE A 130","None","0.78A","1fklA-3o5dA:18.9","1fklA-3o5dA:33.33"],["1FKL_A_RAPA108_1","FK506 BINDING PROTEIN","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",8,"TYR A  57;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.66A","1fklA-3o5dA:18.9","1fklA-3o5dA:33.33"],["1MNV_D_DVAD8_0","ACTINOMYCIN D","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",3,"THR A  15;THR A  17;PRO A  14","None","0.83A","1mnvD-3o5dA:undetectable","1mnvD-3o5dA:4.37"],["1NH8_A_HISA289_0","ATP PHOSPHORIBOSYLTRANSFERASE","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",4,"ASP A 203;LEU A 219;ALA A 205;LEU A 206","None","1.11A","1nh8A-3o5dA:undetectable","1nh8A-3o5dA:22.74"],["1PBK_A_RAPA225_1","FKBP25","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",8,"TYR A  57;ASP A  68;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.78A","1pbkA-3o5dA:18.2","1pbkA-3o5dA:21.18"],["1PBK_A_RAPA225_1","FKBP25","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",8,"TYR A  57;GLY A  84;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.61A","1pbkA-3o5dA:18.2","1pbkA-3o5dA:21.18"],["1Q6I_A_FK5A301_1","FKBP-TYPE PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKPA","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",8,"TYR A  57;ASP A  68;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.82A","1q6iA-3o5dA:14.5","1q6iA-3o5dA:25.18"],["1Q6I_B_FK5B401_1","FKBP-TYPE PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKPA","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",5,"ARG A  73;VAL A  86;ILE A  87;TRP A  90;TYR A 113","None","1.48A","1q6iB-3o5dA:14.4","1q6iB-3o5dA:25.18"],["1Q6I_B_FK5B401_1","FKBP-TYPE PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKPA","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",8,"TYR A  57;ASP A  68;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.70A","1q6iB-3o5dA:14.4","1q6iB-3o5dA:25.18"],["1T6Z_B_RBFB596_1","RIBOFLAVIN KINASE\/FMN ADENYLYLTRANSFERASE","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",5,"VAL A 186;TYR A 243;GLU A 169;LEU A 206;ILE A 202","None","1.28A","1t6zB-3o5dA:undetectable","1t6zB-3o5dA:22.19"],["1TCO_C_FK5C509_2","FK506-BINDING PROTEIN","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.83A","1tcoC-3o5dA:18.5","1tcoC-3o5dA:32.77"],["1XZX_X_T3X500_2","THYROID HORMONE RECEPTOR BETA-1","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",3,"PHE A 225;ARG A 222;ASN A 238","None","0.93A","1xzxX-3o5dA:undetectable","1xzxX-3o5dA:21.40"],["1YAT_A_FK5A108_1","FK506 BINDING PROTEIN","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.80A","1yatA-3o5dA:20.4","1yatA-3o5dA:23.97"],["2DG3_A_RAPA501_1","FK506-BINDING PROTEIN 1A","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",8,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;PHE A 130","None","0.76A","2dg3A-3o5dA:18.8","2dg3A-3o5dA:32.77"],["2DG3_A_RAPA501_1","FK506-BINDING PROTEIN 1A","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",5,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A 122","None","1.19A","2dg3A-3o5dA:18.8","2dg3A-3o5dA:32.77"],["2DG4_A_RAPA501_1","FK506-BINDING PROTEIN 1A","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",7,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TYR A 113;PHE A 130","None","0.74A","2dg4A-3o5dA:18.2","2dg4A-3o5dA:32.20"],["2DG9_A_RAPA501_1","FK506-BINDING PROTEIN 1A","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",6,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;PHE A 130","None","0.62A","2dg9A-3o5dA:18.5","2dg9A-3o5dA:32.20"],["2DG9_A_RAPA501_1","FK506-BINDING PROTEIN 1A","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",5,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A 122","None","1.12A","2dg9A-3o5dA:18.5","2dg9A-3o5dA:32.20"],["2DG9_A_RAPA501_1","FK506-BINDING PROTEIN 1A","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",6,"TYR A  57;PHE A  77;VAL A  86;ILE A  87;TYR A 113;PHE A 130","None","0.48A","2dg9A-3o5dA:18.5","2dg9A-3o5dA:32.20"],["2FKE_A_FK5A108_1","FK506 BINDING PROTEIN","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.77A","2fkeA-3o5dA:18.6","2fkeA-3o5dA:32.77"],["2VCD_A_RAPA138_1","OUTER MEMBRANE PROTEIN MIP","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",7,"TYR A  57;PHE A  67;ASP A  68;VAL A  86;ILE A  87;TRP A  90;TYR A 113","None","1.01A","2vcdA-3o5dA:14.2","2vcdA-3o5dA:21.54"],["2VN1_A_FK5A501_1","70 KDA PEPTIDYLPROLYL ISOMERASE","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",8,"TYR A  57;PHE A  67;ASP A  68;PHE A  77;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.88A","2vn1A-3o5dA:20.6","2vn1A-3o5dA:39.77"],["2VN1_A_FK5A501_1","70 KDA PEPTIDYLPROLYL ISOMERASE","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",8,"TYR A  57;PHE A  67;PHE A  77;VAL A  86;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.75A","2vn1A-3o5dA:20.6","2vn1A-3o5dA:39.77"],["2VN1_B_FK5B501_1","70 KDA PEPTIDYLPROLYL ISOMERASE","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",7,"TYR A  57;ASP A  68;PHE A  77;ILE A  87;TRP A  90;TYR A 113;PHE A 130","None","0.89A","2vn1B-3o5dA:20.6","2vn1B-3o5dA:39.77"],["2VN1_B_FK5B501_1","70 KDA PEPTIDYLPROLYL ISOMERASE","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",7,"TYR A  57;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;PHE A 130","None","0.67A","2vn1B-3o5dA:20.6","2vn1B-3o5dA:39.77"],["3IHZ_A_FK5A501_1","70 KDA PEPTIDYLPROLYL ISOMERASE, PUTATIVE","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.77A","3ihzA-3o5dA:20.3","3ihzA-3o5dA:29.95"],["3IHZ_A_FK5A501_2","70 KDA PEPTIDYLPROLYL ISOMERASE, PUTATIVE;70 KDA PEPTIDYLPROLYL ISOMERASE, PUTATIVE","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",6,"TYR A  57;ASP A  68;PHE A  77;TRP A  90;TYR A 113;ILE A 122","None","0.59A","3ihzB-3o5dA:20.9","3ihzB-3o5dA:29.95"],["3KZ7_A_RAPA225_1","FK506-BINDING PROTEIN 3","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",8,"TYR A  57;ASP A  68;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.78A","3kz7A-3o5dA:18.4","3kz7A-3o5dA:20.83"],["3O5R_A_FK5A1001_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.72A","3o5rA-3o5dA:25.2","3o5rA-3o5dA:88.19"],["3O5R_A_FK5A1001_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",9,"TYR A  57;ASP A  68;VAL A  86;ILE A  87;TRP A  90;TYR A 113;LYS A 121;ILE A 122;PHE A 130","None","0.78A","3o5rA-3o5dA:25.2","3o5rA-3o5dA:88.19"],["3UF8_A_FK5A114_1","UBIQUITIN-LIKE PROTEIN SMT3, PEPTIDYL-PROLYL CIS-TRANS ISOMERASE","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.79A","3uf8A-3o5dA:15.7","3uf8A-3o5dA:24.42"],["3UQA_A_FK5A114_1","UBIQUITIN-LIKE PROTEIN SMT3, PEPTIDYL-PROLYL CIS-TRANS ISOMERASE","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.84A","3uqaA-3o5dA:15.8","3uqaA-3o5dA:24.42"],["3UQB_A_FK5A114_1","UBIQUITIN-LIKE PROTEIN SMT3, PEPTIDYL-PROLYL CIS-TRANS ISOMERASE","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",8,"TYR A  57;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.65A","3uqbA-3o5dA:15.7","3uqbA-3o5dA:25.00"],["3VAW_A_FK5A114_1","UBIQUITIN-LIKE PROTEIN SMT3,PEPTIDYL-PROLYL CIS-TRANS ISOMERASE","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.82A","3vawA-3o5dA:15.4","3vawA-3o5dA:24.81"],["3WQW_A_GCSA502_1","CHITINASE","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",4,"GLY A  93;TRP A  90;ALA A  89;PHE A 129","None","0.98A","3wqwA-3o5dA:undetectable","3wqwA-3o5dA:20.66"],["4BBO_C_ACTC1113_0","BLR5658 PROTEIN","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",4,"ASN A 163;ALA A 253;GLY A 165;THR A 167","None","1.35A","4bboC-3o5dA:undetectable","4bboC-3o5dA:18.99"],["4DRH_A_RAPA201_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",6,"ASP A  68;TRP A  90;TYR A 113;LYS A 121;ILE A 122;PHE A 130","None","1.07A","4drhA-3o5dA:23.4","4drhA-3o5dA:99.31"],["4DRH_A_RAPA201_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",10,"TYR A  57;ASP A  68;PHE A  77;GLN A  85;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.78A","4drhA-3o5dA:23.4","4drhA-3o5dA:99.31"],["4DRH_D_RAPD201_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",10,"TYR A  57;ASP A  68;PHE A  77;GLN A  85;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.81A","4drhD-3o5dA:23.6","4drhD-3o5dA:99.31"],["4DRI_A_RAPA201_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",10,"TYR A  57;ASP A  68;PHE A  77;GLN A  85;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.68A","4driA-3o5dA:23.2","4driA-3o5dA:99.31"],["4DRJ_A_RAPA201_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP4","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.72A","4drjA-3o5dA:22.3","4drjA-3o5dA:61.81"],["4DZ2_A_FK5A200_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE;PEPTIDYL-PROLYL CIS-TRANS ISOMERASE","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.80A","4dz2A-3o5dA:18.9;4dz2B-3o5dA:19.0","4dz2A-3o5dA:34.88;4dz2B-3o5dA:34.88"],["4DZ2_B_FK5B200_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE;PEPTIDYL-PROLYL CIS-TRANS ISOMERASE","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.78A","4dz2A-3o5dA:18.9;4dz2B-3o5dA:19.0","4dz2A-3o5dA:34.88;4dz2B-3o5dA:34.88"],["4DZ3_A_FK5A201_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.80A","4dz3A-3o5dA:19.0","4dz3A-3o5dA:34.88"],["4DZ3_B_FK5B201_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",8,"TYR A  57;ASP A  68;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.80A","4dz3B-3o5dA:19.1","4dz3B-3o5dA:34.88"],["4DZ3_B_FK5B201_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",8,"TYR A  57;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.69A","4dz3B-3o5dA:19.1","4dz3B-3o5dA:34.88"],["4LAX_A_FK5A301_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP4","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",10,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;LYS A 121;ILE A 122;PHE A 130","None","0.84A","4laxA-3o5dA:31.1","4laxA-3o5dA:57.25"],["4NNR_A_FK5A201_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP2;PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP2","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",5,"PHE A  77;TRP A  90;TYR A 113;LYS A 121;ILE A 122","None","0.92A","4nnrA-3o5dA:15.3;4nnrB-3o5dA:15.3","4nnrA-3o5dA:27.94;4nnrB-3o5dA:27.94"],["4NNR_A_FK5A201_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP2;PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP2","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.81A","4nnrA-3o5dA:15.3;4nnrB-3o5dA:15.3","4nnrA-3o5dA:27.94;4nnrB-3o5dA:27.94"],["4NNR_B_FK5B201_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP2","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",8,"TYR A  57;ASP A  68;VAL A  86;ILE A  87;TYR A 113;LYS A 121;ILE A 122;PHE A 130","None","1.06A","4nnrB-3o5dA:15.3","4nnrB-3o5dA:27.94"],["4NNR_B_FK5B201_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP2","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",9,"TYR A  57;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;LYS A 121;ILE A 122;PHE A 130","None","0.85A","4nnrB-3o5dA:15.3","4nnrB-3o5dA:27.94"],["4ODO_A_FK5A205_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE SLYD","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",5,"TYR A  57;ASP A  68;ILE A  87;TYR A 113;PHE A 130","None","0.78A","4odoA-3o5dA:10.4","4odoA-3o5dA:20.75"],["4ODO_B_FK5B203_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE SLYD","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",5,"TYR A  57;ASP A  68;ILE A  87;TYR A 113;PHE A 130","None","0.75A","4odoB-3o5dA:10.0","4odoB-3o5dA:20.75"],["4ODO_C_FK5C204_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE SLYD","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",5,"TYR A  57;ASP A  68;ILE A  87;TYR A 113;PHE A 130","None","0.76A","4odoC-3o5dA:10.1","4odoC-3o5dA:20.75"],["4ODR_A_FK5A201_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE SLYD, PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP1A CHIMERA;PEPTIDYL-PROLYL CIS-TRANS ISOMERASE SLYD, PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP1A CHIMERA","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",6,"TYR A  57;ASP A  68;ILE A  87;TYR A 113;ILE A 122;PHE A 130","None","0.71A","4odrA-3o5dA:11.3;4odrB-3o5dA:11.4","4odrA-3o5dA:16.41;4odrB-3o5dA:16.41"],["4ODR_B_FK5B201_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE SLYD, PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP1A CHIMERA;PEPTIDYL-PROLYL CIS-TRANS ISOMERASE SLYD, PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP1A CHIMERA","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",5,"TYR A  57;ASP A  68;ILE A  87;TYR A 113;PHE A 130","None","0.77A","4odrA-3o5dA:11.3;4odrB-3o5dA:11.4","4odrA-3o5dA:16.41;4odrB-3o5dA:16.41"],["4QT2_A_RAPA202_1","FK506-BINDING PROTEIN (FKBP)-TYPE PEPTIDYL-PROPYL ISOMERASE","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.78A","4qt2A-3o5dA:20.6","4qt2A-3o5dA:34.48"],["4QT3_A_RAPA202_1","FK506-BINDING PROTEIN (FKBP)-TYPE PEPTIDYL-PROPYL ISOMERASE","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.77A","4qt3A-3o5dA:19.4","4qt3A-3o5dA:26.22"],["5B8I_C_FK5C201_3","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.84A","5b8iC-3o5dA:17.9","5b8iC-3o5dA:32.20"],["5D75_A_FK5A301_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP3","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",8,"TYR A  57;ASP A  68;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.79A","5d75A-3o5dA:18.3","5d75A-3o5dA:21.96"],["5GPG_A_RAPA301_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP3","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",8,"TYR A  57;ASP A  68;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.79A","5gpgA-3o5dA:19.1","5gpgA-3o5dA:21.48"],["5HIE_C_P06C801_2","SERINE\/THREONINE-PROTEIN KINASE B-RAF","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",4,"ILE A 122;VAL A  55;CYH A 107;PHE A  79","None","0.98A","5hieC-3o5dA:undetectable","5hieC-3o5dA:22.87"],["5HKG_A_RAPA201_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP1B","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",8,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TYR A 113;ILE A 122;PHE A 130","None","0.70A","5hkgA-3o5dA:18.4","5hkgA-3o5dA:31.64"],["5HUA_A_FK5A201_1","FK506-BINDING PROTEIN 1","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",8,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;PHE A 130","None","0.81A","5huaA-3o5dA:20.6","5huaA-3o5dA:24.07"],["5HW8_A_FK5A201_1","FK506-BINDING PROTEIN 1;FK506-BINDING PROTEIN 1","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",8,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122","None","0.81A","5hw8A-3o5dA:17.1;5hw8D-3o5dA:17.2","5hw8A-3o5dA:27.20;5hw8D-3o5dA:27.20"],["5HW8_B_FK5B201_1","FK506-BINDING PROTEIN 1","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",8,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.78A","5hw8B-3o5dA:17.1","5hw8B-3o5dA:27.20"],["5HW8_C_FK5C201_1","FK506-BINDING PROTEIN 1;FK506-BINDING PROTEIN 1","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",8,"TYR A  57;ASP A  68;VAL A  86;ILE A  87;TRP A  90;TYR A 113;LEU A 128;PHE A 130","None","0.74A","5hw8C-3o5dA:17.0;5hw8H-3o5dA:14.2","5hw8C-3o5dA:27.20;5hw8H-3o5dA:27.20"],["5HW8_D_FK5D201_1","FK506-BINDING PROTEIN 1","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",8,"TYR A  57;ASP A  68;PHE A  77;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.73A","5hw8D-3o5dA:17.2","5hw8D-3o5dA:27.20"],["5HW8_D_FK5D201_1","FK506-BINDING PROTEIN 1","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",8,"TYR A  57;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.68A","5hw8D-3o5dA:17.2","5hw8D-3o5dA:27.20"],["5HW8_E_FK5E201_1","FK506-BINDING PROTEIN 1","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",6,"TYR A  57;ASP A  68;PHE A  77;ILE A  87;TYR A 113;PHE A 130","None","0.82A","5hw8E-3o5dA:17.3","5hw8E-3o5dA:27.20"],["5HW8_E_FK5E201_1","FK506-BINDING PROTEIN 1","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",7,"TYR A  57;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;PHE A 130","None","0.71A","5hw8E-3o5dA:17.3","5hw8E-3o5dA:27.20"],["5HW8_F_FK5F201_1","FK506-BINDING PROTEIN 1;FK506-BINDING PROTEIN 1;FK506-BINDING PROTEIN 1","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",6,"TYR A  57;ASP A  68;PHE A  77;ILE A  87;TYR A 113;PHE A 130","None","0.75A","5hw8B-3o5dA:17.1;5hw8F-3o5dA:14.2;5hw8G-3o5dA:16.6","5hw8B-3o5dA:27.20;5hw8F-3o5dA:27.20;5hw8G-3o5dA:27.20"],["5HW8_F_FK5F201_1","FK506-BINDING PROTEIN 1;FK506-BINDING PROTEIN 1;FK506-BINDING PROTEIN 1","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",7,"TYR A  57;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;PHE A 130","None","0.61A","5hw8B-3o5dA:17.1;5hw8F-3o5dA:14.2;5hw8G-3o5dA:16.6","5hw8B-3o5dA:27.20;5hw8F-3o5dA:27.20;5hw8G-3o5dA:27.20"],["5HW8_G_FK5G201_2","FK506-BINDING PROTEIN 1","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",8,"TYR A  57;ASP A  68;PHE A  77;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.73A","5hw8G-3o5dA:16.6","5hw8G-3o5dA:27.20"],["5HW8_G_FK5G201_2","FK506-BINDING PROTEIN 1","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",7,"TYR A  57;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122","None","1.42A","5hw8G-3o5dA:16.6","5hw8G-3o5dA:27.20"],["5HW8_G_FK5G201_2","FK506-BINDING PROTEIN 1","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",8,"TYR A  57;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.67A","5hw8G-3o5dA:16.6","5hw8G-3o5dA:27.20"],["5HW8_H_FK5H201_1","FK506-BINDING PROTEIN 1","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",6,"TYR A  57;ASP A  68;PHE A  77;ILE A  87;TRP A  90;PHE A 130","None","0.90A","5hw8H-3o5dA:14.2","5hw8H-3o5dA:27.20"],["5HW8_H_FK5H201_1","FK506-BINDING PROTEIN 1","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",6,"TYR A  57;PHE A  77;VAL A  86;ILE A  87;TRP A  90;PHE A 130","None","0.83A","5hw8H-3o5dA:14.2","5hw8H-3o5dA:27.20"],["5HWC_A_FK5A201_1","FK506-BINDING PROTEIN 1A","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.77A","5hwcA-3o5dA:18.6","5hwcA-3o5dA:36.47"],["5VLM_B_CVIB301_0","REGULATORY PROTEIN TETR","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",5,"MET A  97;LEU A 134;ILE A 132;VAL A  86;PHE A  77","None","1.31A","5vlmB-3o5dA:undetectable","5vlmB-3o5dA:22.35"],["5VLM_E_CVIE301_0","REGULATORY PROTEIN TETR","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",5,"MET A  97;LEU A 134;ILE A 132;VAL A  86;PHE A  77","None","1.30A","5vlmE-3o5dA:undetectable","5vlmE-3o5dA:22.35"],["6G9B_A_IXXA609_1","ENVELOPE GLYCOPROTEIN,ENVELOPE GLYCOPROTEIN;ENVELOPE GLYCOPROTEIN","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",4,"LEU A 142;VAL A 245;LEU A 217;LEU A 219","None","0.69A","6g9bA-3o5dA:undetectable;6g9bB-3o5dA:undetectable","6g9bA-3o5dA:15.21;6g9bB-3o5dA:14.88"],["6MKE_A_FK5A201_0","PEPTIDYLPROLYL ISOMERASE","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",6,"ARG A  73;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113","None","1.48A","6mkeA-3o5dA:21.0;6mkeD-3o5dA:20.8","6mkeA-3o5dA:44.44;6mkeD-3o5dA:44.44"],["6MKE_A_FK5A201_0","PEPTIDYLPROLYL ISOMERASE","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.77A","6mkeA-3o5dA:21.0;6mkeD-3o5dA:20.8","6mkeA-3o5dA:44.44;6mkeD-3o5dA:44.44"],["6MKE_B_FK5B201_0","PEPTIDYLPROLYL ISOMERASE","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.75A","6mkeB-3o5dA:20.9;6mkeC-3o5dA:20.7","6mkeB-3o5dA:44.44;6mkeC-3o5dA:44.44"],["6MKE_C_FK5C201_1","PEPTIDYLPROLYL ISOMERASE","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.76A","6mkeC-3o5dA:20.7","6mkeC-3o5dA:44.44"],["6MKE_D_FK5D201_1","PEPTIDYLPROLYL ISOMERASE","3o5d","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.78A","6mkeD-3o5dA:20.8","6mkeD-3o5dA:44.44"]]